Progyny, Inc. (PGNY)

26,52 +0,40 (+1,53%) Alla chiusura: 04:00PM EDT

Progyny, Inc.

1359 Broadway
New York, NY 10018
United States
212 888 3124
https://www.progyny.com

Settore/i: Healthcare
Settore: Health Information Services
Impiegati a tempo pieno: 563

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. David J. Schlanger	Executive Chairman	513,57k	46,8M	1959
Mr. Peter Anevski	CEO & Director	1,09M	21,17M	1967
Mr. Michael Sturmer	President	836,49k	N/D	1977
Mr. Mark S. Livingston	Chief Financial Officer	749,56k	1,36M	1966
Ms. Allison Swartz	Executive VP, General Counsel & Secretary	546,22k	N/D	1990
Mr. Steven Leist	Chief Technology Officer	N/D	N/D	N/D
Mr. James Hart	Vice President of Investor Relations	N/D	N/D	N/D
Ms. Risa Fisher	Chief Marketing Officer	N/D	N/D	N/D
Ms. Cassandra Pratt	Chief Human Resources Officer	N/D	N/D	N/D
Ms. Julie Stadlbauer	Chief Business Development Officer	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Governance aziendale

L'ISS Governance QualityScore di Progyny, Inc. al 1 giugno 2024 è 7. I criteri di valutazione fondamentali sono revisione: 6; Consiglio di Amministrazione: 7; diritti degli azionisti: 7; retribuzione: 8.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.